Professional Documents
Culture Documents
Miskey and Duncan 2001
Miskey and Duncan 2001
net/publication/11878953
CITATIONS READS
69 130
2 authors, including:
Connie C Duncan
Uniformed Services University of the Health Sciences
89 PUBLICATIONS 5,000 CITATIONS
SEE PROFILE
All content following this page was uploaded by Connie C Duncan on 01 August 2014.
The user has requested enhancement of the downloaded file. All in-text references underlined in blue are added to the original document
and are linked to publications on ResearchGate, letting you access and read them immediately.
A Nosology of Disorders of Attention
ALLAN F. MIRSKYa AND CONNIE C. DUNCANa,b
aSectionon Clinical and Experimental Neuropsychology, LBC,
National Institute of Mental Health, Bethesda, Maryland 20892-2615, USA
bClinicalPsychophysiology and Psychopharmacology Laboratory,
Department of Psychiatry, Uniformed Services University of the Health Sciences,
Bethesda, Maryland 20814-4799, USA
ABSTRACT: The trailblazing research on sleep mechanisms and petit mal epi-
lepsy, conducted during the period from 1940 through 1970, illuminated the
brain substrate for normal consciousness and attention, as well as their disor-
ders. This research helped inform and structure our neuropsychologically
based model of the “elements” of attention. The model has been used to assess
attention in the research laboratory and clinic, and has led to a “nosology of
disorders of attention,” which is presented here in preliminary form. The noso-
logy reviews the possible causes of the symptom(s) of impaired attention, as
well as suggesting a blueprint for future research in this area.
KEYWORDS: Attention; Nosology; Sleep; Seizure disorders; Cerebral structures;
Neuropsychological tests.
INTRODUCTION
Address for correspondence: Allan F. Mirsky, Ph.D., Section on Clinical and Experimental
Neuropsychology, LBC, NIMH, NIH, MSC 2615, 5415 W. Cedar Lane, Bethesda, MD
20892-2615. Voice: 301-496-2551.
allan_mirsky@nih.gov
17
18 ANNALS NEW YORK ACADEMY OF SCIENCES
1. The Encode Element: Tests that assess the encode element tap the capacity
to hold information in memory briefly, to enable performance of some
mental operation on the information. Our usage of encode would be equiv-
alent to the term working memory. We proposed that this factor is sup-
ported by brain structures in and around the hippocampus and amygdala.
The Digit Span (WAIS-R, WAIS-III, WISC-R, WISC-III) subtest
taps the subject’s capacity for encoding and retaining in memory a series of
numbers and repeating them immediately. There are two portions of this
test, Digits Forward and Digits Backward.
The Arithmetic (WAIS-R, WAIS-III, WISC-R, WISC-III) subtest
assesses the subjects’s capacity to encode, and retain in memory, arith-
metic word problems, and to solve them without the aid of pencil and
paper.
2. The Focus/Execute Element: Tests of the focus/execute element measure
the capacity to focus on a task in the presence of distracting stimuli, and to
execute quickly the manual or verbal responses required by the task. We
proposed that structures within the inferior parietal lobule, superior tempo-
ral gyrus and parts of the corpus striatum support this aspect of attentive
behavior.
The Digit Symbol Substitution (WAIS-R, WAIS-III) or Coding
(WISC-R, WISC-III) subtest requires the subject to transcribe the sym-
bols paired with the numbers 1 through 9 as quickly as possible, within a
given time limit. The test comprises 100 (or more) digits in random order.
Coding is an equivalent task for children and adolescents.
The Letter Cancellation Test comprises six pages of typed letters of
the alphabet, some of which are capitalized, and some of which are sepa-
rated by double spaces. The task requirements include three variations:
crossing out capital letters, crossing out the letters immediately before and
after a double space, and performing both tasks at once. There is a 60-sec-
ond time limit for each page. The Letter Cancellation Test was originally
described by Talland.23
The Stroop Color-Word Interference Test comprises three forms,
one containing color names, one containing patches of color, and the third
containing color names printed in contrasting ink colors. The subject is
required to read the words (form 1), name the colors (form 2), or name the
color of the ink (form 3) as rapidly as possible during three 45-second
intervals. The version of the Stroop test24 we employ uses stimuli and
instructions described by Golden.25
The Trail Making Test26 consists of two parts. Part A of this timed
task calls for connecting numbers in an ascending sequence, whereas Part
B requires alternation of numbers and letters in an ascending sequence
(i.e., 1-A-2-B-3-C, etc.).
3. The Shift Element: In our analysis, this attentional element is an index of
the capacity to shift attentional focus from one aspect of a complex stimu-
lus to another. The dorsolateral prefrontal cortex and anterior cingulate
gyrus are thought to support this attentional function.
MIRSKY & DUNCAN: NOSOLOGY OF DISORDERS OF ATTENTION 21
THE NOSOLOGY
TABLE 2. Footnotes
aThis is a preliminary classification, based primarily on research we have conducted, or in
which we have collaborated. The references provided are meant only to be illustrative. A full
treatment of the literature on each of these disorders is beyond the scope of this chapter. How-
ever, we believe that there is heuristic value in this preliminary nosology. In many of the disor-
ders listed in TABLE 2, there is an extensive research literature; however, we have chosen to
defer review and discussion.
bThe grouping of attention disorders into categories on the basis of etiology can be beneficial
in a number of ways: 1) It emphasizes the ubiquity of attention disorders, and their manifold cau-
sation; 2) It informs remedial efforts so that they may be maximally effective; 3) It promotes the
scientific analysis of attention disorders and of attention itself.
cIGE = idiopathic generalized epilepsies.
dThese data were derived from a sample of persons from a rural area of Ireland, who possessed
limited education, and may therefore not be representative of patients with higher levels of edu-
cation.
eThe study cited was one in which the subjects were classified as “high-functioning.” Subjects
with lower levels of functioning would be expected to perform more poorly on these tests.
fBased on a single case. We have seen one patient with a diagnosis of narcolepsy, a computer
engineer, who was impaired on virtually all of the tests of the “Attention Battery.” He was fired
from several jobs as a result of his inability to maintain wakefulness and complete assignments.
Our suspicion is that his inability to sustain attention (as evidenced by CPT scores in the
severely impaired range) was the basis of all of his other deficits. The literature suggests that
most patients with this diagnosis would be impaired on tests such as the CPT. 84,85
gAs an example of the benefits accruing to the systematic approach to disordered attention, we
cite a hypothetical case which may nevertheless be very common. A six-year-old child is
referred for evaluation of her “daydreaming and failure to pay attention in class.” In some juris-
dictions/institutions, depending on the resources and time available to the school psychologist, a
diagnosis would be made within short order that the child is suffering from some form of atten-
tion deficit disorder, with or without hyperactivity. With the compliance of a physician, the child
would be placed on stimulant medication, most likely, methylphenidate (Ritalin) or dextro-
amphetamine. After several weeks, during which time the dose of the drug would be increased, it
would be apparent that the medication was ineffective, and if anything, the child would be less
responsive and more distracted in class than ever.
In another scenario, which may follow (or replace) the one described above, the school psy-
chologist, who had been trained in neuropsychology, conducts a comprehensive and informed
evaluation of the various aspects of attention in the child. 8 The results of that examination,
which would include the Continuous Performance Test or CPT, indicate that the omission errors
made by the child suggest a failure of vigilance, rather than the impulsivity associated with
ADHD. Consequently, the school psychologist would recommend that the child be given an
EEG examination to rule out the presence of a generalized seizure disorder, such as childhood
absence epilepsy. The examination reveals the tell-tale three-per-second symmetrical and syn-
chronous spike-and-wave pattern of absence epilepsy. The child would be placed on the anticon-
vulsant medication sodium valproate, and the attention problem would improve considerably
within a few days.
This example illustrates the importance of having a more comprehensive view of the nature
and causes of attention impairment, and the value of knowledge that there can be more causes of
disordered attention than ADD/ADHD.
hThe data were derived from a population of inner-city children with ADHD, many of whom
had other diagnoses (e.g., learning disabilities, oppositional conduct disorder, etc.). The ubiqui-
tous deficits seen in this population may not be representative of what is seen in middle-class
children with this diagnosis, but nevertheless call attention to the overwhelming need for inter-
vention and remediation in this segment of our population.
24 ANNALS NEW YORK ACADEMY OF SCIENCES
The proposed nosology emphasizes the fact that all symptoms of impaired attention
do not stem from the same cause. Instead, they may have a variety of causes that
comprise a number of broad categories. It is with systematization in mind that we
began to develop a comprehensive nosology of disorders of attention.
TABLE 2 summarizes the proposed nosology of disorders of attention. It includes
relevant references, usually from our own research, concerning the specific atten-
tional elements that have been found to be impaired in the disorders.
The following caveat is in order: The evidence for the inheritance of disorders
such as schizophrenia, attention-deficit hyperactivity disorder (ADHD), and
idiopathic generalized epilepsy is clear; however, other data suggest that there may
be a genetic component in most complex human disorders—and a number of these
have the symptom of impaired attention. Therefore, the proposed categorization in
TABLE 2 will have to be altered as evidence is gathered regarding the genetic contri-
bution to other disorders.
Familial/Genetic Etiologies
Probably the major research effort in this field has involved the assessment of
attention in first-degree relatives of patients with schizophrenic disorders. Our stud-
ies in Ireland and Israel, as well as those from the New York High-Risk Project, have
provided ample evidence of the attentional deficit in first-degree relatives of patients
with schizophrenia. This deficit is manifest primarily in measures of sustained atten-
tion, such as the CPT.14,18,31,52
The findings of impaired attention in the relatives of patients with schizophrenia
provided a stimulus for studies in other familial/genetic disorders, such as idiopathic
generalized epilepsy.53–55 A major focus of our research effort over the past decade
has been concerned with identifying familial/genetic influences in the neuropsycho-
logical deficits seen in generalized epilepsy. We were the first to report that there is
a distinct neuropsychological deficit found in patients with absence epilepsy—man-
ifest in impaired sustained attention—a finding that we (and others) have replicated
a number of times in succeeding years.8,10–12,29,33,56,57 Lansdell and Mirsky12
reported, as well, that female patients with the disorder performed more poorly on
the CPT than male patients. Levav59 replicated this result and also found that there
is a significant tendency for female, but not male, parents of patients with absence
epilepsy to share (in milder form) the deficits seen in the probands themselves.59
This result mirrors the finding that absence epilepsy tends to be inherited in the
maternal line.53–55
Most recently, we have found that relatives of patients with juvenile myoclonic
epilepsy (JME)—another form of idiopathic generalized epilepsy—may also share
some of the deficits in visual and auditory sustained attention seen in the probands.33
We are actively pursuing the implications of these findings for the burgeoning field
of the genetic analysis of the idiopathic epilepsies (e.g., refs. 60, 61). Thus, the work
of Greenberg and colleagues suggests that there is an “epilepsy gene,” identified
through linkage analysis, which is apparently present for both probands and relatives
of probands with JME. The location of this gene is in the human lymphocyte
MIRSKY & DUNCAN: NOSOLOGY OF DISORDERS OF ATTENTION 25
Metabolic Etiologies
In his studies of end-stage uremia, Murawski36 reported that patients with this
disorder exhibited impairment of sustained attention, as measured by the CPT. The
impairment of attention was particularly intriguing in view of the finding that end-
stage uremia is sometimes accompanied by an EEG pattern that resembles that seen
in absence epilepsy.76 This report encouraged the belief that the toxins associated
with kidney failure attacked the same “centrencephalic” brainstem structures impli-
cated in absence epilepsy.6 Subsequent studies of uremic patients have confirmed the
neurotoxic effects of kidney failure, including the presence of an abnormal EEG,77
and the development of convulsions that may be generalized.78,79 In addition,
MIRSKY & DUNCAN: NOSOLOGY OF DISORDERS OF ATTENTION 27
one study reported abnormal performance of dialyzed uremic patients on the Trail
Making Test.38
Environmental Etiologies
Other Etiologies
CONCLUDING REMARKS
The data summarized in TABLE 2, especially the numerous “?” entries, indicate
that there are many aspects that remain to be investigated from the point of view of
the model of attention proposed here. The data also suggest that whereas there may
be considerable heterogeneity in the attentional deficits associated with neuropsy-
chiatric disorders, there may be a substantial degree of homogeneity as well. Thus,
of the sixteen etiologies listed in the tables, there is evidence of impaired sustained
attention, as assessed by the CPT, in eleven. The next most frequent listing is impair-
ment in the capacity to shift attention (assessed by the WCST), seen in eight of the
etiologies.
If our theorizing about the cerebral structures that support sustained attention is
correct, this would suggest that compromise of brainstem and/or midline thalamic
structures would appear to be a common feature of all the disorders in which
impaired CPT functioning is seen. This would not be subject to much discussion
with respect to absence and other forms of idiopathic epilepsy,6 possibly end-stage
uremia76–79 and perhaps some forms of schizophrenia.81,82 However, whether and
how this subcortical brain system is compromised in the other disorders remains to
be demonstrated. Nevertheless, with the imaging techniques now available to eluci-
date brain dysfunction, it may be possible to identify which cerebral structures are
implicated in the attention impairment in these common and troubling disorders.
The paper by Rosvold, Mirsky, et al. that was the first to describe the application
of the CPT to the study of impaired attention9 has been referenced in the literature
approximately 800 times. The widespread adoption of this technique for studying
sustained attention is evident in the numerous commercial versions of the CPT that
are currently on the market. The paper on the analysis of elements of attention8 has
been cited 125 times, as of the end of the last century. Those two publications would
appear to have had a salutary influence on the scientific study of attention and its
clinical application. Our hope is that this discussion of the nosology of attention dis-
orders may serve to promote further study of the disorders of attention, as well as of
our model and its applicability.
REFERENCES
1. M IRSKY, A.F. & P.V. C ARDON. 1962. A comparison of the behavioral and physiologi-
cal changes accompanying sleep deprivation and chlorpromazine administration in
man. Electroencephalogr. Clin. Neurophysiol. 14: 1–10.
2. M IRSKY, A.F. & E. B AKAY P RAGAY. 1967. The relation of EEG and performance in
altered states of consciousness. In Sleep and Altered States of Consciousness. E.V.
Evarts, Ed.: 514–534. Williams & Wilkins. Baltimore.
3. M ORUZZI, G. & H.W. M AGOUN. 1949. Brain stem reticular formation and activation of
the EEG. Electroenceph. Clin. Neurophysiol. 1: 455–473.
4. L INDSLEY, D.B., J.W. B OWDEN & H.W. M AGOUN. 1949. Effect upon the EEG of acute
injury to the brain stem activating system. Electroenceph. Clin. Neurophysiol. 1:
475–486.
5. L INDSLEY, D.B. 1960. Attention, consciousness, sleep and wakefulness. In Handbook
of Physiology. J. Field, H.W. Magoun & V.E. Hall, Eds.: 1553–1593. American
Physiological Society. Washington, DC.
6. P ENFIELD, W. & H. J ASPER. 1954. Epilepsy and the Functional Anatomy of the Human
Brain. Little, Brown. Boston.
MIRSKY & DUNCAN: NOSOLOGY OF DISORDERS OF ATTENTION 29
31. M IRSKY, A.F., B.D. F ANTIE & J.E. T ATMAN. 1995. Assessment of attention across the
lifespan. In Clinical Neuropsychological Assessment: A Cognitive Approach. R.L.
Mapou & J. Spector, Eds.: 17–48. Plenum. New York.
32. M IRSKY, A.F. 1995. Perils and pitfalls on the path to normal potential: the role of
impaired attention. Homage to Herbert G. Birch. J. Clin. Exp. Neuropsychol. 17: 1–
18.
33. L EVAV, M., A.F. M IRSKY, J. H ERAULT, et al. Is there familial association of neuropsy-
chological characteristics in patients with generalized and partial seizure disorders?
In review.
34. P ASCUALVACA, D., B.F F ANTIE, M. P APAGEORGIOU, et al. 1998. Attention capacities in
children with autism: is there a general deficit in shifting focus? J. Autism Dev. Dis-
ord. 28: 467–478.
35. A NDERSEN, V.E. & F.S. S IEGEL. 1967. Behavior and inborn errors of metabolism.
Paper presented in a symposium at the meeting of the American Psychological Asso-
ciation, Washington, DC, September 4, 1967.
36. A NDERSEN, V.E., F.S. S IEGEL, R.O. F ISCH, et al. 1969. Responses of phenylketonuric
children on a continuous performance test. J. Abnorm. Psychol. 74: 358–362.
37. M URAWSKI, B.J. 1970. The continuous performance test: a measure of sustained atten-
tion in human uremics. In Proceedings of the Workshop on Bioassays in Uremia.
R.B. Coletti & K.K. Krueger, Eds.: 72–73. U.S. Government Printing Office. Wash-
ington, DC.
38. R ATNER, D.P., K.M. A DAMS, N.W. L EVIN, et al. 1983. Effects of hemodialysis on the
cognitive and sensory-motor functioning of the adult chronic hemodialysis patient.
6: 291–311.
39. L EVAV, M., A.F. M IRSKY, P.M. S CHANTZ, et al. 1995. Parasitic infestation in malnour-
ished school children: effects on behavior and EEG. Parasitology 110: 103–111.
40. L EVAV, M., M.E. C RUZ & A.F. M IRSKY. 1995. EEG abnormalities, malnutrition, para-
sitism and goiter: a study of children in Ecuador. Acta Paediatr. 84: 197–202.
41. N EEDLEMAN, H.L., J.A. R EISS, M.J. T OBIN, et al. 1995. Bone lead levels and delin-
quent behavior. J. Am. Med. Assoc. 275: 363–369.
42. M IRSKY, A.F., S. K ELLAM, A. T ODD, et al. Effects of lead on measures of sustained
attention: a k-xray investigation. In preparation.
43. C HAMBERLIN, R., G. C HAMBERLAIN, B. H OWLETT, et al. 1975. British Births 1970.
Volume I: The First Weeks of Life. Heineman Medical Books. London.
44. C HAMBERLIN, R., G. C HAMBERLAIN, B. H OWLETT, et al. 1978. British Births 1970.
Volume II: Obstetrical Care. Heineman Medical Books. London.
45. S TREISSGUTH, A.P., P.D. S AMPSON, H. C ARMICHAEL O LSON, et al. 1994. Maternal
drinking during pregnancy: attention and short-term memory performance in 14-
year-old offspring: a longitudinal prospective study. Alcohol. Clin Exp. Res. 18:
202–218.
46. L EVAV, M., A.F. M IRSKY, M.E. C RUZ & I. C RUZ. 1995. Neurocysticercosis and per-
formance on neuropsychological tests: a family study in Ecuador. Am. J. Trop. Med.
Hyg. 53: 552–557.
47. C RUZ, M.E., M. L EVAV, I. R AMIREZ, et al. 1993. Niveles de nutricion y rendimiento en
pruebas neuropsicologicas en niños escolares de una comunidad rural andina. Parasi-
tos Cerebral e Intestinal Problemas de Salud Publica. Academia Ecuatoriana de Neu-
rociencias. Quito, Ecuador.
48. B AHARUDIN, R. & T. L USTER. 1998. Factors related to the quality of the home environ-
ment and children’s achievement. J. Fam. Issues 19: 375–403.
49. Z AHN, T.P. & A.F. M IRSKY. 1999. Reaction time indicators of attention deficits in
closed head injury. J. Clin. Exp. Neuropsychol. 21: 352–367.
50. G REENBLATT, R.M. 1986. The effects of brain stem compression on attention and
memory. Diss. Abstr. Int. 47: 1301B.
51. R EGESTEIN, Q., M. P AVLOVA, R. G LEASON, et al. Vigilance testing in patients referred
for sleep breathing disorder. In review.
MIRSKY & DUNCAN: NOSOLOGY OF DISORDERS OF ATTENTION 31
52. E RLENMEYER-K IMLING L. & B.A. C ORNBLATT. 1985. Attentional measures in a study
of children at high-risk for schizophrenia. In The Nature of Schizophrenia: New
Approaches to Research and Treatment. L.C. Wynne, R.L. Cromwell & S. Mattyse,
Eds.: 359–365. Wiley. New York.
53. M ETRAKOS, J.D.. & K. M ETRAKOS. 1960. Genetics of consulsive disorders. Introduc-
tion, problems, methods and baselines. Neurology 10: 228–240.
54. M ETRAKOS, K. & J.D. M ETRAKOS. 1961. Genetics of consulsive disorders. II. Genetic
and electroencephalographic studies in centrencephalic epilepsy. Neurology 11:
474–483.
55. O TTMAN R., W.A. H AUSER & M. S USSER. 1985. Genetic and maternal influences on
susceptability to seizures—an analytic review. Am. J. Epidemiol. 122: 923–939.
56. M IRSKY, A.F. & C.C. D UNCAN. 1990. Behavioral and electrophysiological studies of
absence epilepsy. In Generalized Epilepsy: Neurobiological Approaches. N. Avoli,
P. Gloor, G. Kostopoulos, et al., Eds.: 254–269. Plenum. New York.
57. M IRSKY, A.F., C.C. D UNCAN & M. L EVAV. 2000. Neuropsychological studies in idio-
pathic generalized epilepsy. In Neuropsychology of Childhood Epilepsy. I. Jam-
baqué, M. Lassonde & O. Dulac, Eds. Plenum. New York. In press.
58. L EVAV, M., A.F. M IRSKY, J. H ERAULT, et al. 1997. Familial characteristics of cogni-
tive impairment in epilepsy. Epilepsia 38: 133.
59. L EVAV, M. 1992. Attention performance in children affected with absence epilepsy
and their first-degree relatives. Dissertation Abstracts Int. 53: 1454.
60. G REENBERG D.A., A.V. D ELGADO-E SCUETA, H. W IDELITZ, et al. 1988. Juvenile myo-
clonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome
6. Am. J. Med. Genet. 31: 185–192.
61. G REENBERG, D.A., M. D URNER, M. K EDDACHE, et al. 2000. Reproducibilty and com-
plications in gene searches: linkage on chromosome 6, heterogeneity, and maternal
inheritanace in juvenile myoclonic epilepsy. Am. J. Human Genet. 66: 508–516.
62. G REENBERG, D.A., M. D URNER, S. S HINNAR, et al. 1996. Association of HLA class II
alleles in patients with juvenile myoclonic epilepsy compared to other patients with
other forms of adolescent onset generalized epilepsy. Neurology 47: 750–755.
63. D URNER, M., T. S ANDER, D.A. G REENBERG, et al. 1991. Localization of idiopathic
generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy
patients. Neurology 41: 1651–1655.
64. W EISSBECKER, K.A., M. D URNER, D. J ANZ, et al. 1991. Confirmation of linkage
between juvenile myoclonic epilepsy and the HLA-region of chromosome 6. Am. J.
Med. Genet. 38: 32–36.
65. B RZUSTOWICZ, W.G., H ONER, E.W. C HOW, et al. 1997. Use of a quantitative trail to
map a locus associated with severity of positive symptoms in familial schizophrenia
to chromosome 6p. Am. J. Human Genet. 61: 1388–1396.
66. M OISES, H.W., L. Y ANG, H. K RISTBJARNSON, et al. 1995. An international two-stage
genome-wide search for schizophrenia susceptibility genes. Nature Genet. 11: 321–
324.
67. O DELL, J.D., R.P. W ARREN, R.A. B URGER, et al. 1997. Association of genes within the
major histocompatibility complex with attention deficit hyperactivity disorder. Neu-
ropsychobiology 35: 181–186.
68. B ROWN, M.R., M.S. T OMEK, L. V AN L EAR, et al. 1997. A novel locus for autosomal
dominant nonsyndromic hearing loss, DFNA13, maps to chromosome 6p. Am. J.
Human Genet. 61: 924–927.
69. P ORTER, R.J. 1993. The absence epilepsies. Epilepsia 34 (Suppl. 3): S42–S48.
70. N OEBELS, J. 1995. Single-locus mutations in mice expressing generalized spike-wave
absence epilepsies. Ital. J. Neurol. Sci. 16: 107–111.
71. B ARCLAY, J. & M. R EES 1999. Mouse models of spike-wave epilepsy. Epilepsia 40
(Suppl. 3): 17–22.
72. W OERMANN, F.G., S.M. S OSODIYA, S.L. F REE & J.S. Duncan. 1998. Quantitative MRI
in patients with idiopathic generalized epilepsy: evidence of widespread cerebral
structural changes. Brain 121: 1661–1667.
73. D URNER, M., D.A. G REENBERG, S. S HINNAR, et al. 1999. Genome search in idiopathic
generalized epilepsy. Epilepsia 40 (Suppl. 7): 164.
32 ANNALS NEW YORK ACADEMY OF SCIENCES
74. A NONYMOUS. April 2000. National Center for Biotechnology, National Library of
Medicine Web Site.
75. B ARKLEY, R.A. 1999. Response inhibition in attention-deficit hyperactivity disorder.
Ment. Retard. Development. Disab. Res. Rev. 5: 177–184.
76. O LSEN, S. 1961. The brain in uremia. Acta Psychiat. Scand. 36(Suppl.): 129.
77. T ESCHAN, P.E. 1975. Electroencephalographic and other neurophysiological abnor-
malities in uremia. Kidney Int. Suppl. 2: 210–216.
78. L OCKWOOD, A.H. 1989. Neurologic complications of renal disease. Neurol. Clin. 7:
612-627.
79. B URN, D.J. & D. B ATES. 1998. Neurology and the kidney. J. Neurol. Neurosurg. Psy-
chiatry 65: 810–821.
80. C RAVIOTO, J., E.R. D ELICARDIE & H.G. B IRCH. 1966. Nutrition, growth and neurointe-
grative development. An experimental and ecologic study. Pediatrics 38 (Suppl.):
319–372.
81. H ARELL, M., M. E NGLENDER, M. D EMER, et al. 1986. Auditory brain stem responses in
schizophrenic patients. Laryngoscope 96: 908–910.
82. K ARSON, C.N., E. G ARCIA-R ILL, W.S. G RIFFIN, et al. 1991. The brainstem reticular
formation in schizophrenia. Biol. Psychiatry 29: 90.
83. A NONYMOUS A UTHOR. April 2000. Science, The Human Gene Map. National Center
for Biotechnology, National Library of Medicine Web Site.
84. B ILLIARD, M. & J. S EIGNALET. 1985. Extraordinary association between HLA-DR2
and narcolepsy. Lancet 1(8422): 226–227.
85. A LDRICH, M.S. 1991. The neurobiology of narcolepsy. Trends Neurosci. 14: 235–239.